Publications of Marta Anglada-Huguet

Anglada-Huguet, M.; Endepols, H.; Sydow, A.; Hilgers, R.; Neumaier, B.; Drzezga, A.; Kaniyappan, S.; Mandelkow, E.; Mandelkow, E.-M.: Reversal of Tau-dependent cognitive decay by blocking adenosine A1 receptors: Comparison of transgenic mouse models with different levels of tauopathy. International Journal of Molecular Sciences 24 (11), 9260 (2023)

Endepols, H.; Anglada-Huguet, M.; Mandelkow, E.; Schmidt, Y.; Krapf, P.; Zlatopolskiy, B. D.; Neumaier, B.; Drzezga, A.: Assessment of the in vivo relationship between cerebral hypometabolism, Tau deposition, TSPO expression, and synaptic density in a tauopathy mouse model: a multi-tracer PET study. Molecular Neurobiology 59 (6), pp. 3402 - 3413 (2022)

Green, C.; Sydow, A.; Vogel, S.; Anglada-Huguet, M.; Wiedermann, D.; Mandelkow, E.; Mandelkow, E.-M.; Höhn, M.: Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model. Molecular Neurodegeneration 14, 13 (2019)

Barriga, G. G.-D.; Giralt, A.; Anglada-Huguet, M.; Gaja-Capdevila, N.; Orlandi, J. G.; Soriano, J.; Canals, J.-M.; Alberch, J.: 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington’s disease mouse model through specific activation of the PLCc1 pathway. Human Molecular Genetics 26 (16), pp. 3144 - 3160 (2017)

Joseph, M.; Anglada-Huguet, M.; Paesler, K.; Mandelkow, E.; Mandelkow, E.-M.: Anti-aggregant tau mutant promotes neurogenesis. Molecular Neurodegeneration 12, 88 (2017)